Comprehensive chronic disease management
Chronic diseases have become a major public health challenge, posing a significant threat to national health and driving the increase in medical expenses. Drawing on its deep technical expertise and innovative research capabilities in the field of in vitro diagnostics, Wantai Biopharm has developed a comprehensive solution for chronic disease management based on precision medicine. With the core principles of "early screening, early diagnosis, and early intervention", the solution offers individuals and medical institutions scientific, systematic tools for chronic disease management through high-precision detection and intelligent management.
By integrating biomarker detection, digital health management, and clinical support, we establish a closed-loop management model that spans "prevention → screening → management → follow-up". This approach fully aligns with the "Healthy China 2030 Strategy", supporting the shift in chronic disease prevention and control from a "treatment-centered" model to one that is "prevention-centered". Our solution also fosters the development of public health services toward specialization, precision, and intelligence.
Accurate detection plan
Scientifically Developing a Multidimensional Screening and Risk Assessment System for Chronic Diseases
Tumor Screening and Treatment Monitoring Solution
Based on multiple tumor marker detection technologies, Wantai BioPharm can provide 27 tumor marker detection parameters. It can simultaneously assess the risks and prognosis monitoring of multiple common tumors, including lung cancer, liver cancer, gastric cancer, colorectal cancer, nasopharyngeal cancer, etc., effectively improving the early diagnosis rate and survival rate of tumors.
- Combined Screening for Multiple Cancers-ComprehensiveOne test can simultaneously assess the incidence risks of multiple common tumors
- Unaffected by Biotin-AccurateThe acridinium ester direct chemiluminescence technology is not affected by health products (containing biotin components) and some medications.
- Risk Assessment and Management-ModelProvides diagnostic models for liver cancer, lung cancer, ovarian cancer, and nasopharyngeal cancer to achieve hierarchical management.
- Comprehensive Assessment ReportProvides multi-dimensional tumor risk assessment reports and follow-up suggestions.
Cardiovascular Health Assessment
Aiming at cardiovascular diseases, which is the leading cause of death globally, Wantai BioPharm can provide a comprehensive testing solution based on heart diseases, hypertension, and thrombosis. Through precise quantitative analysis of key indicators such as cardiovascular-related markers, it realizes the early warning and dynamic monitoring of cardiovascular disease risks.
- Multi-index DetectionComprehensive analysis of 15 myocardial markers to comprehensively assess cardiovascular health status.
- High-precision QuantificationAdopts high-precision quantitative analysis technology, and the test results are accurate and reliable.
- Risk Early Warning ModelA cardiovascular disease risk early warning model based on big data realizes individualized risk assessment.
- Long-term Monitoring SolutionProvides a long-term monitoring solution for high-risk groups and dynamically assesses the intervention effect.
Brain Disease Management
For neurodegenerative diseases, particularly Alzheimer's disease, Wantai Biopharm offers an early screening solution based on multiple biomarkers. By combining the detection and analysis of 11 brain-related biomarkers with cognitive function assessments, this solution enables a comprehensive evaluation and early risk warning for brain diseases.
- Combined Detection of Multiple BiomarkersThrough the combined detection and analysis of relevant biomarkers, the detection accuracy is improved.
- Cognitive Function AssessmentCombined with professional cognitive function assessment tools, it assesses the health status of the nervous system from multiple dimensions.
- Early Intervention GuidanceProvides personalized intervention suggestions based on the test results to delay the progression of the disease.
- Regular Monitoring SolutionFormulates a long-term monitoring plan to timely detect changes in the function of the nervous system.
Metabolic Health Management
For metabolic diseases such as diabetes, Wantai BioPharm has developed a comprehensive testing and management solution. By detecting key indicators such as glucose metabolism and bone metabolism, it assesses the metabolic health status and realizes early disease intervention and long-term management.
- Panoramic View of Metabolic HealthAssesses the metabolic health status from multiple dimensions and establishes a personal metabolic health record.
- Precise Risk StratificationConducts precise risk stratification according to the test results and formulates personalized intervention strategies.
- Lifestyle InterventionProvides personalized lifestyle intervention suggestions based on the test results.
- Dynamic Health ManagementThrough regular testing and assessment, it realizes the dynamic management of metabolic health.
Core Advantages
Based on the concept of precision medicine, we provide comprehensive and systematic solutions for chronic disease management
Accurate detection
Adopting advanced detection technology and multi biomarker joint analysis strategy, high-precision disease risk assessment and early screening are achieved, with a leading clinical compliance rate among peers.
Full Coverage
The testing parameters cover multiple key chronic disease areas such as the nervous system, cardiovascular disease, and cancer, achieving "one-stop" screening and meeting the needs of comprehensive health management.
Data Driven
Based on massive clinical data and deep learning algorithms, a precise risk assessment model is constructed to support personalized health management decisions and intervention strategies.
Closed-loop Management
From screening to intervention and follow-up, establish a complete chronic disease management loop to achieve long-term health monitoring and management effectiveness evaluation.
Covering the field of health
Comprehensively covering key chronic disease management areas and building a comprehensive health defense line
Lung Health
Early Screening and Management of Pulmonary Diseases
Heart Health
Risk assessment of heart diseases such as coronary heart disease and heart failure
Brain Health
Screening for neurodegenerative diseases such as Alzheimer's disease
Liver Health
Assessment of liver diseases such as hepatitis, liver fibrosis, and liver cancer
Stomach Health
Screening for gastric diseases such as atrophic gastritis and gastric cancer
Nasopharyngeal Health
Early risk assessment of nasopharyngeal carcinoma and related diseases
Technical advantages
Creating high-quality chronic disease management solutions with leading technology and clinical experience
Leading clinical compliance rate
The chronic disease detection solution of Wantai BioPharm is based on strict clinical verification. Multi-center clinical studies are used to verify the performance of each detection parameter, ensuring that the detection results are highly consistent with clinical diagnoses and providing a reliable basis for medical decision-making.
- Strict clinical validation process to ensure testing quality
- Multi center clinical research support, reliable data
- High sensitivity and specificity, improving detection accuracy
Comprehensive analysis of multiple biomarkers
Different from the traditional single-index detection, Wantai BioPharm adopts the technology of combined detection and analysis of multiple markers. By comprehensively evaluating multiple related markers, it significantly improves the sensitivity and specificity of early disease screening, reducing false positive and false negative results.
- Multi index joint analysis to improve diagnostic accuracy
- Intelligent algorithm support, optimized detection result analysis
- Personalized reference interval to improve clinical relevance of results
Intelligent Health Management Platform
The intelligent health management platform developed by Wantai BioPharm seamlessly integrates detection data with health management. Through data analysis and intelligent algorithms, it provides users with personalized health management plans and intervention suggestions, realizing the maximum value transformation of the detection data.
- Long term tracking of health data and establishment of personal health records
- AI assisted analysis provides personalized health recommendations
- Dynamic risk assessment, continuous optimization of health management plans
For more information : wtexport@ystwt.com
Filing Number:(京)网药械信息备字（2025）第 00190 号
|
Copyright©Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
|
|
京公网安备11011402010353号 
Alibaba Cloud provides cloud computing and security services.|
It supports
|
Powered by CloudDream
|
Terms Of Use|
Privacy Statement